CIK 0001783183 · Non-accelerated filer<br>Smaller reporting company
Phathom Pharmaceuticals, Inc.
Sign in to watch- Ticker
- PHAT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 824151574
- Phone
- (877) 742-8466
- Business address
- 100 CAMPUS DRIVE,, SUITE 102, FLORHAM PARK, NJ, 07932
- 8-K Event Bylaws or fiscal year change · Shareholder vote results · Other events
- SC 13D/A Stake Beneficial Ownership Report
- 8-K Event Other events
- 424B5 Offering Prospectus
- 424B5 Offering Prospectus
- 8-K Event Other events
- 4 Planned sale CFO and CBO sold 2,110 shares at $12.87 ($27,165)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- SC 13D/A Stake Beneficial Ownership Report
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- ARS Other Annual Report to Security Holders
- 4 Open-market buy Director bought 1,000 shares at $7.55 ($7,550)
- 4 Open-market buy Chief Operating Officer bought 10,000 shares at $8.26 ($82,600)
- 4 Open-market buy President and Chief Executive bought 12,919 shares at $7.82 ($101,025)
- 4 Planned sale CFO and CBO sold 3,439 shares at $7.27 ($25,002)
- 8-K Event Other events
- PRE 14A Proxy Proxy Statement (Preliminary)
- SC 13G Stake Amended Statement of Ownership
Page 12 of 25 · 496 filings